TR201906195T4 - Niemann pıck hastalığının teşhisi için metot. - Google Patents

Niemann pıck hastalığının teşhisi için metot. Download PDF

Info

Publication number
TR201906195T4
TR201906195T4 TR2019/06195T TR201906195T TR201906195T4 TR 201906195 T4 TR201906195 T4 TR 201906195T4 TR 2019/06195 T TR2019/06195 T TR 2019/06195T TR 201906195 T TR201906195 T TR 201906195T TR 201906195 T4 TR201906195 T4 TR 201906195T4
Authority
TR
Turkey
Prior art keywords
pick disease
niemann pick
subject
diagnosing niemann
diagnosing
Prior art date
Application number
TR2019/06195T
Other languages
English (en)
Inventor
Rolfs Arndt
Mascher Hermann
Original Assignee
Centogene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centogene Ag filed Critical Centogene Ag
Publication of TR201906195T4 publication Critical patent/TR201906195T4/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Buluş, bir denekteki Niemann Pick hastalığının teşhisi için bir metot, bir denekteki Niemann Pick hastalığının seyrinin belirlenmesi için bir metot, Niemann Pick hastalığının tanısı içerisinde bir biyolojik işaretleyicinin tespit edilmesi için bir deneğe kütle spektrometrik analizin kullanımı ile uygulanmış olan en az bir tedavinin etkinliğini belirlemek için bir metot, ve bir denekten alınan bir numune içerisinde biyolojik işaretleyicinin varlığının tespit edilmesi için bir kit ile alakalıdır.
TR2019/06195T 2013-05-14 2014-05-14 Niemann pıck hastalığının teşhisi için metot. TR201906195T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13002515 2013-05-14

Publications (1)

Publication Number Publication Date
TR201906195T4 true TR201906195T4 (tr) 2019-05-21

Family

ID=48428310

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/06195T TR201906195T4 (tr) 2013-05-14 2014-05-14 Niemann pıck hastalığının teşhisi için metot.

Country Status (10)

Country Link
US (1) US10302664B2 (tr)
EP (1) EP2997384B1 (tr)
JP (2) JP6660291B2 (tr)
CA (1) CA2912274A1 (tr)
CY (1) CY1121790T1 (tr)
DK (1) DK2997384T3 (tr)
ES (1) ES2731920T3 (tr)
SA (1) SA515370129B1 (tr)
TR (1) TR201906195T4 (tr)
WO (1) WO2014183873A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE047863T2 (hu) * 2013-06-07 2020-05-28 Genzyme Corp Marker savas szfingomielináz rendellenességekhez és alkalmazásai
AU2015349030A1 (en) * 2014-11-19 2017-05-04 Centogene Gmbh Method for the diagnosis of Niemann-Pick disease using a biomarker

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908190D0 (en) * 1999-04-09 1999-06-02 Pharming Intellectual Pty Bv Diagnosis of lysosomal storage disorders using saposins and other markers
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
JP4833831B2 (ja) * 2003-03-31 2011-12-07 ウイミンズ、アンド、チルドランズ、ホスピトル リソソーム蓄積症（ｌｄｓ）の多重スクリーニング
EP1691819A4 (en) * 2003-11-25 2009-05-06 Sinai School Medicine THERAPY ON CHAPERON BASIS FOR NIEMANN PICK DISEASE
EP1922326A4 (en) * 2006-03-24 2011-06-01 Phenomenome Discoveries Inc BIOMARKERS USEFUL FOR DIAGNOSING PROSTATE CANCER AND METHOD OF USE THEREOF
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
ES2902229T3 (es) * 2009-08-28 2022-03-25 Icahn School Med Mount Sinai Terapia de sustitución de la enzima de escalado de la dosis para el tratamiento de la deficiencia de esfingomielinasa ácida

Also Published As

Publication number Publication date
SA515370129B1 (ar) 2019-11-18
US10302664B2 (en) 2019-05-28
JP6989636B2 (ja) 2022-01-05
JP2016522406A (ja) 2016-07-28
EP2997384A1 (en) 2016-03-23
DK2997384T3 (da) 2019-07-22
CA2912274A1 (en) 2014-11-20
US20160109470A1 (en) 2016-04-21
EP2997384B1 (en) 2019-04-10
ES2731920T3 (es) 2019-11-19
JP6660291B2 (ja) 2020-03-11
CY1121790T1 (el) 2020-07-31
JP2020101554A (ja) 2020-07-02
WO2014183873A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
EA201590027A1 (ru) Способы детекции заболеваний или состояний
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
TR201904386T4 (tr) Nükleotidleri içeren nükleozomların saptanmasına yönelik yöntem.
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
EA201290711A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
BR112015019614A8 (pt) análise de imagens e medições de amostras biológicas
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
EA201490999A1 (ru) Способ проведения количественных анализов
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
EA201370063A1 (ru) Фосфолипидом рака
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
TR201819546T4 (tr) Numune tür kökeni için tespit yöntemleri.
CY1122360T1 (el) Μεθοδος για τη διαγνωση της νοσου niemann-pick
TR201902171T4 (tr) Bir numune içindeki bir molekülün yakalanmasına yönelik metot.
EP2569635A4 (en) METHODS OF DIAGNOSING AND TREATING ENCEPHALITY OR EPILEPSY
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
WO2014053996A3 (en) Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs
BR112022011676A2 (pt) Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma